Details of the Drug Reposition

General Information of This Drug (ID: DMZVLY8)

• Drug Name: Nadrolone phenylpropionate (DMZVLY8)
• Synonyms: Nandrolone phenpropionate; nandrolone phenylpropionate; 62-90-8; Nortestosterone phenylpropionate; Nandrolon phenylpropionate; Nadrolone phenylpropionate; Nerobolil; Fenobolin; Nandrolin; Norandrostenolone phenylpropionate; Superanabolon; Phenobolin; Norandrolone phenyl propionate; NTPP; Durabolin; Durabol; 19Ntpp; Norandrolone phenylpropionate; Nandrolone Phenylpionate; Nerobil; Activin; UNII-KF7Z9K2T3W; Nandrobolic; Anticatabolin; Strabolene; KF7Z9K2T3W; Sintabolin; Equibolin; Norandrol; Anabosan; Hybolin; CHEBI:7468; Nandrolone phenpro
• Drug Type: Small molecular drug

Information on Drug Reposition of This Drug

2 Approved Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Advanced cancer	DISAT1Z9	2A00-2F9Z	Approved	[1]
Malnutrition	DIS1UUNY	5B50-5B71	Approved	[1]

References

• [1] A standard database for drug repositioning. Sci Data. 2017 Mar 14;4:170029.